Steroids, Antihistamines and Glaucoma: Which Everyday Medicines Your Eye Doctor Asks About

The question usually arrives at the pharmacy counter, not in the consulting room. A box of hay fever tablets, a cold remedy, a steroid cream for a stubborn patch of eczema, and there on the leaflet, in small type: “Do not use if you have glaucoma.” The person holding the box has had drops for glaucoma for three years and has never once been told to stop buying antihistamines. So which is it?

That moment of doubt is exactly why eye clinics ask about every pill, inhaler, patch and ointment at each visit. Medications that affect glaucoma are a short but genuinely important list, and the risk is not the same for every person. For someone with open-angle glaucoma, a week of allergy tablets is usually a non-event, while a long course of oral steroids deserves a pressure check. For someone with narrow drainage angles, the priorities flip.

This explainer walks through what each group of medicines actually does inside the eye, who needs to be cautious, and what the evidence supports, so the next leaflet warning feels less like a cliff edge and more like a prompt for a sensible conversation.

Why does your eye doctor ask about every pill, puffer and drop?

Glaucoma is a group of conditions in which the optic nerve, the cable carrying images from the eye to the brain, is slowly damaged, most often in the setting of raised pressure inside the eye. The eye makes a clear fluid called aqueous humor behind the iris, and that fluid drains out through a mesh of tissue, the trabecular meshwork, sitting in the angle where the iris meets the cornea. Pressure rises when production outpaces drainage, much like a sink with a partly blocked outlet.

Medicines can disturb this balance in three distinct ways. Some, principally corticosteroids, change the drainage mesh itself so fluid leaves more slowly. Others widen the pupil, which in a person with a crowded, shallow front chamber can push the iris against the drain and shut it, a sudden event called angle closure. A third, rarer group causes the structures behind the iris to swell and shove the whole drainage angle forward.

Only the first mechanism is relevant to the common open-angle form, in which the angle looks open on examination but the mesh itself functions poorly. The second and third are the concern for narrow angles. That distinction is why an honest answer to “Is this medicine safe for me?” depends on knowing which type of glaucoma, or which anatomy, a person has, something the eye examination establishes rather than the leaflet.

Most of the medicines involved are ordinary ones. People do not usually think to mention a steroid nasal spray or a travel-sickness patch, yet both can matter. The clinic’s medication question is not a formality; it is part of the pressure assessment, and it works best when the answer is complete.

What is narrow-angle glaucoma, and why does it change the medicine conversation?

Narrow-angle glaucoma, also called angle-closure glaucoma, occurs when the iris bulges forward and blocks or narrows the drainage angle. It can happen gradually, with no symptoms until the optic nerve is already damaged, or abruptly as an acute attack, which is a medical emergency. The Mayo Clinic describes the acute form as presenting with severe eye pain, headache, nausea, blurred vision and colored halos around lights, often with a red eye.

Who is at risk? Anatomy sets the stage. People who are farsighted tend to have shorter eyes with shallower front chambers. The lens thickens with age and pushes the iris forward, so risk climbs in later decades. Women and people of East Asian or South Asian heritage are more commonly affected, according to the NHS and Mayo Clinic. Many people with narrow angles have no idea; the shape of the angle is seen only when an eye specialist examines it with a special contact lens, a test called gonioscopy.

Here is the part that matters for medicines. Any drug that widens the pupil or thickens the iris can be the trigger that converts a narrow angle into a closed one. That is the mechanism behind most of the warnings on antihistamine, decongestant and antidepressant leaflets. Once an eye specialist has treated narrow angles, typically with a laser that makes a tiny opening in the iris, called a peripheral iridotomy, the pupil-widening risk falls dramatically, and many of those warnings no longer apply in the same way.

So the practical question is not “Do I have glaucoma?” but “Has anyone told me my angles are narrow, and if so, have they been treated?” If the answer is unknown, the eye clinic can settle it in a single visit.

Medications that affect glaucoma: the main groups at a glance

The table below gathers the groups that come up repeatedly in guidance from the Mayo Clinic, Cleveland Clinic and NHS. It describes mechanism and the type of glaucoma most affected. It is not a list of medicines to stop; it is a list of medicines to mention.

Medicine group (examples by class or generic name)	How it can affect the eye	Main concern for
Corticosteroids: eye drops, tablets, injections, inhalers, nasal sprays, skin creams	Slow outflow through the drainage mesh; pressure rises over weeks	Open-angle glaucoma, steroid responders, anyone on long courses
First-generation antihistamines (e.g., diphenhydramine, chlorpheniramine)	Anticholinergic effect widens the pupil	Untreated narrow angles
Decongestants (e.g., pseudoephedrine, phenylephrine)	Stimulate pupil-dilating muscle	Untreated narrow angles
Anticholinergics for bladder, bowel, motion sickness, Parkinson’s (e.g., oxybutynin, scopolamine)	Widen the pupil	Untreated narrow angles
Tricyclic antidepressants; some SSRIs and SNRIs	Pupil widening via anticholinergic or serotonergic action	Untreated narrow angles
Topiramate and some sulfa-related drugs	Swelling behind the iris pushes the angle shut, rarely	Anyone, including open angles; usually within early weeks of use
Inhaled anticholinergic bronchodilators (e.g., ipratropium) if mist reaches the eye	Local pupil widening	Untreated narrow angles

Two patterns stand out. Steroids are the only common group that quietly raises pressure in the open-angle form, which is by far the more common type. Nearly everything else on the list is a narrow-angle story, and much of that risk is removed once narrow angles have been treated. Keeping those two columns separate prevents a great deal of unnecessary worry and, occasionally, unnecessary risk.

Steroids and eye pressure: the one that matters for everyone with glaucoma

Corticosteroids are the medicines most worth a dedicated conversation, because they can raise pressure through any route, in people with open angles, and without any warning symptoms. The Mayo Clinic lists corticosteroid use, particularly eye drops, among the recognised risk factors for glaucoma.

The mechanism is in the drainage mesh. Steroids change the proteins and matrix laid down in the trabecular meshwork and reduce the cells’ ability to clear debris, so the outflow channels become stiffer and less permeable. The effect is dose-dependent and builds gradually; classic ophthalmology studies found that a sizeable minority of the general population show a measurable pressure rise with sustained topical steroid use, and that the proportion is considerably higher in people who already have open-angle glaucoma or a close relative with it. These people are often described as steroid responders.

Route matters, but no route is exempt. Eye drops and injections around or into the eye deliver the highest concentration and carry the greatest risk. Tablets and intravenous courses come next. Inhalers and nasal sprays used for asthma, COPD and rhinitis deliver far smaller amounts, and large population studies have produced mixed findings, with any risk appearing small and tied to higher doses over long periods. Skin creams are a concern mainly when used on the eyelids or around the eye.

Timeline is the reassuring part. Pressure usually climbs over weeks of continuous use, not after a single dose, and in most people it returns toward baseline within weeks of stopping. A short burst of oral steroids for a chest infection is rarely a problem, though it is worth mentioning. A months-long course for an inflammatory condition is different and typically prompts a pressure check from the eye clinic. Nobody should stop a prescribed steroid on their own; the prescriber and eye specialist can coordinate monitoring or alternatives.

Antihistamines and glaucoma: what the warning label actually means

The glaucoma warning on allergy medicines is probably the most misunderstood line in any leaflet. It exists because older, first-generation antihistamines such as diphenhydramine, chlorpheniramine and promethazine have anticholinergic activity, meaning they block the chemical acetylcholine in nerves that control, among other things, the muscle that constricts the pupil. A wider pupil in a shallow front chamber can push the iris into the drainage angle. That is a narrow-angle problem.

Newer, second-generation antihistamines such as loratadine, cetirizine and fexofenadine have little anticholinergic effect and are generally not considered a meaningful trigger for angle closure, although leaflets still often carry a cautious note. Antihistamine eye drops for itchy eyes act locally and are not usually flagged.

For the person with open-angle glaucoma on drops, which is most people with the condition, there is no good evidence that occasional antihistamine use affects pressure or the course of the disease. The anticholinergic mechanism does nothing to the drainage mesh itself. That person’s eye specialist will almost always say the seasonal allergy tablet is fine.

The situation differs for someone with narrow angles that have not been treated, or who has never been examined and has risk features: farsightedness, older age, a family history of acute glaucoma. For them, a first-generation antihistamine, especially combined with a decongestant in a cold-and-flu product, is a genuine, if uncommon, trigger. The sensible route is a gonioscopy examination to find out, after which most people learn either that their angles are open or that a simple laser procedure has removed the concern.

The honest summary of antihistamines and glaucoma: the warning is real but narrow in scope, and it is aimed at anatomy, not at the diagnosis most people carry.

Decongestants, motion-sickness patches and other anticholinergic medicines

Beyond antihistamines, a whole family of everyday medicines shares the pupil-widening effect, and they tend to be the ones people forget to mention. Decongestants work differently from antihistamines but reach the same place: pseudoephedrine and phenylephrine stimulate the adrenergic receptors that pull the pupil open. Nasal sprays containing these drugs deliver less to the eye than tablets, but the leaflet warning is the same.

Anticholinergic medicines appear in surprising places:

• Bladder drugs for overactive bladder, such as oxybutynin and solifenacin.
• Antispasmodics for irritable bowel, such as hyoscine (also sold as scopolamine) and dicyclomine.
• Motion-sickness patches worn behind the ear, which release scopolamine continuously; touching the patch and then the eye can widen one pupil dramatically.
• Some Parkinson’s disease medicines, including trihexyphenidyl and benztropine.
• Inhaled bronchodilators such as ipratropium and tiotropium, mainly when nebulizer mist drifts into the eyes.
• Muscle relaxants and certain anti-nausea drugs with anticholinergic properties.

The eye clinic’s own dilating drops belong on this list too. The drops used to widen the pupil for a retinal examination are chosen precisely because they are strong, which is why the examiner checks the angle first in anyone at risk and why acute angle closure after a routine eye test is a recognised, though rare, event.

For open-angle glaucoma, none of these medicines is thought to change the drainage mesh or the disease course, and people on glaucoma drops take them routinely. For untreated narrow angles, each is a potential trigger. The right response to the list is not avoidance but disclosure: tell the eye clinic and the prescriber, and let them match the medicine to the anatomy. In many cases there is an equally effective alternative without the anticholinergic effect, and the prescriber is the right person to make that swap.

Antidepressants, migraine and seizure medicines: topiramate and the swelling angle

Mental health and neurology prescriptions carry some of the most frequently queried glaucoma warnings, and they deserve a careful, non-alarmist explanation, because stopping these medicines abruptly can be far more dangerous than the eye risk they carry.

Tricyclic antidepressants such as amitriptyline and nortriptyline are strongly anticholinergic and widen the pupil; the concern is again for untreated narrow angles. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs) have far weaker anticholinergic activity, but published case reports and some database studies have linked them with angle closure in susceptible eyes, probably through serotonin’s own effect on pupil size. The absolute risk is low, and for open-angle glaucoma there is no consistent evidence of harm.

Topiramate is different, and worth knowing by name. Used for epilepsy and migraine prevention, it can, in a small number of people, cause fluid to collect in the tissue behind the iris and swell the ciliary body, the ring of muscle that holds the lens. The whole lens-iris diaphragm shifts forward and the angle closes, in both eyes at once, regardless of whether the angles were narrow to begin with. Reports describe this occurring most often in the first few weeks of treatment, sometimes within days, with sudden blurred near vision, eye pain and redness. It is rare, reversible when the drug is stopped under medical supervision, and distinct from the pupil mechanism; a laser iridotomy does not fix it because the iris is not the problem. Other sulfa-derived drugs, including acetazolamide, which is itself a glaucoma medicine, have very occasionally been linked to the same reaction.

The message for anyone starting these medicines is simple: new eye pain or a sudden change in vision in the early weeks is worth same-day attention, and the prescriber should know about any glaucoma diagnosis before the first prescription, not after.

Medications to avoid with glaucoma: a realistic list, not a ban

People searching for medications to avoid with glaucoma usually want a tidy list. The honest answer is that the list depends on the person, and “avoid” is rarely the right verb. A better framework is three questions.

First, which type of glaucoma, or which anatomy? For open-angle glaucoma, the group to watch is corticosteroids, and the response is monitoring rather than avoidance; many people with glaucoma take steroids for asthma, arthritis or skin disease with periodic pressure checks. For untreated narrow angles, the pupil-widening groups are the concern, and the usual fix is a laser procedure that removes the risk rather than a lifetime of reading leaflets.

Second, what is the route and duration? A steroid tablet course of a few days, a single dilated eye examination, or an occasional antihistamine carries a very different weight from months of steroid drops or a daily anticholinergic bladder tablet. The eye clinic weighs these differently, and so should the person taking them.

Third, what is the medicine for? Antidepressants, anti-seizure drugs and Parkinson’s medicines treat serious conditions, and stopping them without a plan can cause real harm. The NHS and Mayo Clinic both emphasise that medicine changes should be made with the prescriber, who can usually find a substitute with a cleaner eye profile when one is needed.

What people with glaucoma can usefully do:

• Keep a current medicine list, including sprays, creams, patches and over-the-counter products, and bring it to every eye appointment.
• Tell every prescriber and pharmacist about the glaucoma diagnosis and, if known, whether the angles are open or narrow.
• Ask the eye clinic whether a steroid course warrants a pressure check and when.
• Treat sudden eye pain or vision change after starting any new medicine as a same-day problem.

Handled this way, the warning on the box becomes a conversation starter rather than a reason to go without treatment that is needed.

Who is usually asked to pause or watch, and who can usually carry on

Eye specialists sort people into broad groups when a flagged medicine comes up. These are patterns, not rules, and the individual decision rests with the treating team.

Usually able to carry on, with routine monitoring: people with open-angle glaucoma or ocular hypertension (raised pressure without nerve damage) who are starting a non-steroid medicine. Antihistamines, decongestants, bladder drugs and antidepressants do not act on the drainage mesh, and there is no good evidence they worsen open-angle disease. People whose narrow angles have already been treated with a laser iridotomy also usually fall here, since the pupil-widening mechanism no longer closes the angle in the same way.

Usually asked to watch, with an extra pressure check: anyone with glaucoma, a strong family history, or a known steroid response who is starting a corticosteroid for more than a short burst, by any route, and particularly as eye drops, injections around the eye, or long-term tablets. The Mayo Clinic lists long-term steroid use as a risk factor, and the pressure rise is silent, so measurement is the only way to know. People starting topiramate are also often asked to report any early visual change promptly.

Usually asked to pause, or to have the medicine changed, before continuing: people with untreated narrow angles, or with a prior acute attack in one eye and an untreated fellow eye, who are prescribed a pupil-widening medicine. In practice the pause is often brief: the laser procedure is quick, and once done, the medicine can frequently be resumed. In the meantime, the prescriber may choose a non-anticholinergic alternative.

Pregnancy, kidney disease and heart or lung conditions do not change the eye risk, but they do change which glaucoma drops are suitable, which is a separate conversation covered below. In every case, the person who prescribes the systemic medicine and the eye specialist need to be talking to each other, and the simplest way to make that happen is for the patient to tell both.

Which glaucoma eye drops are used, and what are the side effects of beta-blocker drops?

Treatment for most glaucoma starts with eye drops that lower pressure, either by reducing fluid production or by improving drainage. The Mayo Clinic groups them into six main classes.

Prostaglandin analogs (for example latanoprost, bimatoprost, travoprost) increase outflow and are often the first drop prescribed. Reported side effects include eye redness and stinging, darkening of the iris and of the skin around the eye, and longer, thicker eyelashes.

Beta-blocker drops (for example timolol, betaxolol) reduce fluid production. Because the drop drains through the tear duct into the nose and is absorbed into the bloodstream, side effects can be systemic: the Mayo Clinic lists difficulty breathing, a slowed heart rate, lower blood pressure, fatigue and impotence. People with asthma, COPD, heart block or very slow heart rates are often steered to other classes. Pressing a finger gently on the inner corner of the eye for a minute or two after instilling the drop, a technique called punctal occlusion, reduces how much reaches the bloodstream; the clinic can demonstrate it.

Alpha-adrenergic agonists (brimonidine, apraclonidine) both reduce production and increase outflow; reported effects include irregular heartbeat, high blood pressure, fatigue, red, itchy or swollen eyes and dry mouth. Carbonic anhydrase inhibitors as drops (dorzolamide, brinzolamide) can cause a metallic taste, frequent urination and tingling in the fingers and toes; the tablet forms carry these effects more strongly. Rho kinase inhibitors (netarsudil) are newer and most often cause redness. Miotic drops (pilocarpine) constrict the pupil, which helps open a narrow angle, with headache, dim or blurred vision and brow ache as the common complaints.

None of these should be started, stopped or swapped without the eye specialist; abruptly stopping a beta-blocker drop, for instance, can let pressure rebound. Reporting side effects, rather than quietly skipping doses, is the surest way to end up on a drop that fits.

Is there a "most effective" glaucoma medication?

The search phrase “most effective medication for glaucoma” gets typed thousands of times a month, and it does not have a single answer, because effectiveness in glaucoma means two different things: how much a drop lowers pressure on a chart, and how well it protects a particular person’s optic nerve over decades.

On the first measure, prostaglandin analogs are generally the class that produces the largest average pressure reduction with once-daily use, which is why guidelines from the NHS and the Mayo Clinic describe them as a usual first choice for open-angle glaucoma. That is a population average, not a guarantee; a meaningful minority of people respond less to prostaglandins and better to another class, and the eye specialist discovers this by measuring pressure after a trial period.

On the second measure, the most effective medication is whichever one a person actually uses, every day, without side effects that drive them to stop. A drop that lowers pressure beautifully in a trial but leaves someone with red, stinging eyes and a drawer full of unused bottles is not effective for that person. This is why clinics ask about adherence without judgement, why once-daily regimens are preferred where possible, and why combination drops exist that put two agents in one bottle.

Effectiveness also depends on the type of glaucoma. In narrow-angle disease, the most useful intervention is often not a drop at all but a laser iridotomy, with drops used alongside. In some open-angle cases, laser treatment of the drainage mesh, called selective laser trabeculoplasty, is offered as a first-line option; the NHS describes laser and surgery as part of the standard pathway rather than a last resort.

So the useful question for a consultation is not “Which drop is best?” but “What target pressure are we aiming for, and which option gets me there with the fewest problems?” The answer is individual by design.

What the days and weeks after starting a flagged medicine usually look like

Timelines differ sharply between the two mechanisms, and knowing the difference tells a person what to watch for and when.

Steroids work slowly. Pressure typically begins to rise after sustained use over several weeks rather than days, and continues to climb while the steroid continues, with no symptoms at all. For eye drops or injections near the eye, specialists often schedule a pressure check within the first few weeks and again later; for tablets and inhalers, the interval is usually longer and based on dose and duration. When a steroid is stopped under supervision, pressure usually drifts back toward baseline over the following weeks, though a small number of people need pressure-lowering drops in the meantime, and rarely the rise persists. Because nothing is felt, the only reliable monitoring is measurement, which is why the eye clinic wants to know the course has started.

Pupil-widening medicines act fast. If an untreated narrow angle is going to close, it tends to happen within hours of a dose, often in the evening when the pupil is naturally larger in dim light. The Mayo Clinic’s description of acute angle closure applies here: severe eye pain, headache, nausea or vomiting, blurred vision, halos around lights, a red eye and sometimes a pupil that looks mid-sized and fixed. This is an emergency; treatment the same day protects the nerve.

Topiramate sits between the two: reports place most reactions in the first few weeks of treatment, and the early sign is often a sudden shift toward nearsightedness, with distance vision blurring, before pain develops.

For the majority, who have open angles and start a non-steroid medicine, the following weeks look like nothing at all, and the next routine glaucoma visit is the appropriate check. The NHS recommends regular review for everyone with glaucoma regardless, so that visit is already in the diary.

What people often get wrong about medications that affect glaucoma

Several myths circulate on this topic, and most do harm in one of two directions: needless avoidance of useful medicines, or false reassurance.

Myth: “The leaflet says glaucoma, so I can’t take it.” Most leaflet warnings refer to untreated narrow angles. For the far more common open-angle form, antihistamines, decongestants and bladder medicines are not known to affect the drainage mesh. The right step is to ask, not to go untreated.

Myth: “I’m on glaucoma drops, so my pressure is handled whatever else I take.” Drops lower pressure; they do not block a steroid’s effect on the mesh. A long steroid course can push pressure above target in someone whose drops were working well, and nothing will feel different. Monitoring is the answer.

Myth: “Inhalers and nasal sprays don’t count.” The dose reaching the eye is small, and the evidence for risk is modest, but these products still belong on the medication list, especially at higher doses over years, and especially for steroid responders.

Myth: “Once I’ve had the laser treatment, nothing can close my angle.” A peripheral iridotomy removes the usual pupil-block mechanism, which is why most warnings stop applying afterwards. It does not prevent the rare topiramate-type reaction, which works by a different route.

Myth: “If my eye hurt from a medicine, I’d know straight away.” True for angle closure, false for steroids. The steroid pressure rise is painless; that is exactly why it is dangerous.

Myth: “Natural supplements are safe for glaucoma.” There is no supplement with good evidence for lowering pressure or protecting the optic nerve, and some herbal products have anticholinergic properties of their own. The NIH Office of Dietary Supplements is a reliable place to check individual ingredients, and the eye clinic should hear about them.

Myth: “Stopping the medicine is safer than asking.” Stopping an antidepressant, a seizure drug or a steroid abruptly can be far riskier than the eye question it raises. The prescriber and eye specialist can almost always find a safe path together.

Questions to ask your care team

A short, specific set of questions turns a rushed appointment into a plan. These are the ones eye specialists and pharmacists say they wish more people asked.

• Which type of glaucoma do I have, and have my drainage angles been examined with gonioscopy? Are they open, narrow, or narrow but already treated?
• Given my type, which medicine groups actually matter for me, and which leaflet warnings can I set aside?
• If I am prescribed a corticosteroid, by any route, when should my pressure be checked, and who arranges that check?
• Am I a known steroid responder? Has my pressure ever risen on a steroid before?
• Is there a note in my records, and on my pharmacy profile, that flags narrow angles or a steroid response so future prescribers see it?
• For my current drops, which side effects should I report, and which are expected and harmless?
• If a beta-blocker drop is part of my treatment, does my heart or lung history change that choice, and should I use the punctal occlusion technique?
• What is my target pressure, and how will we know the current treatment is reaching it?
• If I need a cold remedy, allergy tablet or travel-sickness product, is there a class you would prefer I use?
• What symptoms after a new medicine should bring me in the same day, and how do I reach the clinic out of hours?

Bring the full medicine list, including over-the-counter products, creams, sprays, patches and supplements, written down or photographed. Ask for the answers to be recorded in the clinic letter so the family doctor and pharmacist share the same information. The goal is a system in which the glaucoma diagnosis travels with every prescription, so that nobody has to make a judgement call at the pharmacy counter with a leaflet and a guess.

When to call your doctor

Most medicine questions in glaucoma can wait for a routine appointment or a phone call. A few cannot. Seek same-day or emergency eye care if any of the following develops after starting or increasing a medicine, or at any other time:

• Sudden, severe pain in or around one eye, especially with headache, nausea or vomiting.
• Sudden blurred or dim vision, or a sudden shift toward nearsightedness in both eyes.
• Rainbow-colored halos around lights, particularly in the evening.
• A red eye combined with any of the above, or a pupil that looks larger than the other and does not react to light.
• Any abrupt loss of part of the visual field.

These are the features the Mayo Clinic and NHS describe for acute angle closure, which can damage the optic nerve within hours if untreated. Do not wait for the morning, and do not take another dose of the suspected medicine while waiting to be seen; tell the emergency team what has been started recently.

Contact the eye clinic or prescriber promptly, though not necessarily as an emergency, if:

• A steroid course of more than a short burst has been started by any route and no pressure check has been arranged.
• A new medicine with a glaucoma warning has been prescribed and no one has confirmed whether it is suitable for your angle type.
• Glaucoma drops are causing breathlessness, a very slow pulse, faintness, palpitations or marked fatigue, which can signal systemic absorption of a beta-blocker or alpha-agonist drop.
• Drops are being missed because of side effects; a swap is usually possible.

Every decision about continuing, pausing or changing a medicine, whether a steroid, an antidepressant or a glaucoma drop, belongs with the treating team, who can weigh the eye risk against everything else the medicine is doing. The patient’s job, and it is a crucial one, is to make sure they have the full picture.

Frequently asked questions

What medications should glaucoma patients avoid?

It depends on the type of glaucoma. People with open-angle glaucoma mainly need pressure monitoring on corticosteroids, by any route, rather than avoidance. People with untreated narrow angles are usually asked to steer clear of pupil-widening medicines such as first-generation antihistamines, decongestants, anticholinergic bladder and bowel drugs, motion-sickness patches and tricyclic antidepressants until a laser procedure has been done. Topiramate warrants caution for everyone. No prescribed medicine should be stopped without the prescriber’s agreement.

What is narrow-angle glaucoma?

Narrow-angle, or angle-closure, glaucoma occurs when the iris bulges forward and blocks the drainage angle where fluid leaves the eye, causing pressure to rise. It can be gradual and silent or sudden and painful, with severe eye pain, headache, nausea, blurred vision and halos around lights. Farsighted people, older adults, women and people of Asian heritage are more often affected. An eye specialist identifies narrow angles with gonioscopy and commonly treats them with a laser iridotomy.

What is the most effective medication for glaucoma?

There is no single most effective medication. Prostaglandin analog drops produce the largest average pressure reduction and are usually the first choice for open-angle glaucoma, according to NHS and Mayo Clinic guidance, but individual response varies and some people do better on another class. For narrow angles, laser treatment often matters more than drops. The effective medicine is the one that reaches a person’s target pressure and is used every day without intolerable side effects.

What are the possible side effects of using beta-blocker eye drops?

Beta-blocker drops such as timolol drain through the tear duct and are absorbed into the body, so side effects can be systemic. The Mayo Clinic lists difficulty breathing, a slowed heart rate, lower blood pressure, fatigue and impotence. People with asthma, COPD, heart block or a very slow pulse are often offered another class. Gentle pressure on the inner corner of the eye after instilling the drop reduces absorption. Report breathlessness or faintness to the clinic promptly.

Can I take antihistamines if I have glaucoma?

Most people with open-angle glaucoma can, because antihistamines do not affect the eye’s drainage mesh. The leaflet warning concerns untreated narrow angles, where older first-generation antihistamines with anticholinergic effects can widen the pupil and close the angle. Second-generation antihistamines carry much less of this effect. If you do not know whether your angles are open, ask the eye clinic; a single examination settles it, and treated narrow angles usually remove the concern.

Which narrow angle glaucoma medications are used, and which are avoided?

For narrow angles, the central treatment is usually a laser peripheral iridotomy that creates a small drainage opening in the iris; pilocarpine drops, which constrict the pupil, may be used alongside, and pressure-lowering drops are added as needed. Medicines usually avoided until the angle is treated include pupil-widening drugs: first-generation antihistamines, decongestants, anticholinergics and tricyclic antidepressants. Topiramate is a separate concern. The eye specialist tailors both lists to the individual.

Do steroid inhalers and nasal sprays raise eye pressure?

They can, but the amount reaching the eye is far smaller than with steroid eye drops, injections or tablets, and large studies have found any added risk to be small and tied mainly to higher doses over long periods. Steroid responders and people with existing glaucoma are the most susceptible. Inhalers and sprays still belong on the medication list given to the eye clinic, which may adjust the frequency of pressure checks. Nobody should stop a prescribed inhaler without the prescriber’s advice.

How long does it take for steroids to raise eye pressure?

The rise usually develops gradually over weeks of continuous use rather than after a single dose, and it causes no symptoms. Eye drops and injections near the eye act fastest and most strongly; tablets and inhaled or nasal steroids are slower and weaker. After a steroid is stopped under supervision, pressure typically returns toward baseline over the following weeks, although a small number of people need temporary pressure-lowering drops or, rarely, longer-term treatment.

Can antidepressants cause glaucoma?

They do not cause the common open-angle form. Tricyclic antidepressants are strongly anticholinergic and can trigger angle closure in someone with untreated narrow angles; SSRIs and SNRIs carry a much smaller, mainly case-report level risk through the same route. The absolute risk is low. Antidepressants should never be stopped abruptly because of an eye concern; the prescriber and eye specialist can arrange an angle examination and, if needed, a laser procedure or an alternative medicine.

Is it safe to have my pupils dilated at an eye exam if I have glaucoma?

For open-angle glaucoma, yes; dilating drops do not affect the drainage mesh and the examination is routine. For narrow angles, dilation can rarely trigger angle closure, which is why the examiner checks the angle first and may advise laser treatment beforehand or use weaker drops with a pressure check afterwards. Tell the clinic about any history of narrow angles or a previous acute attack, and report pain or halos after the appointment the same day.

References

• NHS: Glaucoma
• MedlinePlus: Glaucoma
• National Eye Institute (NIH): Glaucoma
• Cleveland Clinic: Glaucoma

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.